Change Language

Select Language

到2024年,全球医用大麻市场将达到444亿美元,并由临床试验和研发投资培养

Published on Oct 09, 2018

As per the latest research report by IMARC Group, titled “医用大麻市场:全球行业趋势,份额,规模,增长,机会和预测2019-2024”, theglobal medical cannabis marketreached a value of US$ 13.4 Billion in 2018. Medical cannabis is obtained from the Cannabis Sativa and Cannabis Indica plants. It contains three major active compounds namely, Cannabidiol (CBD), Tetrahydrocannabinol (THC) and Cannabinol (CBN). As compared to recreational cannabis, medical cannabis has a lower amount of THC and a higher count of CBD which provides therapeutic advantages to patients and aids in retaining anti-psychotic effects. This plant-based drug is gradually gaining acceptance in the pharmaceutical industry as it helps in improving the mood, immune function and vascular health. It is now used for curing anxiety, nausea, depression, chronic pain and side effects of multiple sclerosis, epilepsy, PTSD and Parkinson’s disease. It is prescribed in different forms like vapor, oral capsules, topical solutions, creams and balms.

Market Drivers:

与其他治疗替代方案相比,大麻更安全,副作用较少。因此,它与其他治疗方法结合使用,可以打击副作用或提高其有效性。例如,它与传统的阿片类止痛药一起使用,使患者能够逐渐降低阿片类药物的频率和剂量。此外,由于老年患者更有可能患上慢性疾病并需要频繁的医生就诊,因此人口稳定的人口在促进对医用大麻的需求方面发挥了至关重要的作用。除此之外,制造商还投资研发活动和临床试验,以开发更安全的大麻形式。预计医用大麻的进一步合法化将推动全球市场增长。由于这些因素,预计市场将在2019 - 2024年的复合年增长率增长22.9%,到2024年的价值为444亿美元。

Market Segmentation:

  • There are three major species including Sativa, Indica and Hybrid. Currently, Indica cannabis accounts for the dominant share. It has a higher yield as compared to sativa with a higher content of CBD which is utilized in the treatment of insomnia and for relieving headache, body pain and migraine.
  • On the basis of derivatives, the market has been divided into Tetrahydrocannabinol (THC), Cannabidiol (CBD) and others. Presently, CBD is extensively used for medical purposes as it comprises low levels of toxicity when compared to THC.
  • Medical cannabis finds application in the treatment of cancer, arthritis, migraine, epilepsy and others. Amongst these, cancer represents the most popular application area of this drug, holding the largest market share.
  • 在最终用途的基础上,制药行业代表领先的领域,这是占主导地位的占主导地位。其次是开发中心和其他最终用途。
  • The market has been segregated based on different routes of administration like vaporizers, smoking, topicals, oral solutions and capsules, and others. At present, oral solutions and capsules dominate the market.
  • On the geographical front, Europe, Latin America, North America, Middle East and Africa, and Asia Pacific are the major markets, wherein North America represents the leading region. It has been further categorized into Canada and the United States, whereas Europe is classified as Italy, France, Germany, Spain and the Netherlands.
  • On analyzing the competitive landscape of the industry, it has been found that GW Pharmaceuticals, Aurora Cannabis, Inc., Canopy Growth Corporation, Aphria Inc., MedReleaf Corporation, Cara Therapeutics, Inc., Insys Therapeutics, Inc., United Cannabis Corporation and CanniMed Therapeutics, Inc. are major players.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC的信息产品包括针对制药,工业和高科技组织的商业领导者的主要市场,科学,经济和技术发展。对生物技术,高级材料,药品,食品和旅游,旅行和旅游,纳米技术和新颖加工方法的市场预测和行业分析是公司专业知识的首位。

联系我们

欧宝电竞首页

USA:+1-631-791-1145
电子邮件:sales@imarcgroup.com
网站://www.cflgrp.com
Follow us on twitter:@imarcglobal

REACH OUT TO US

打电话给我们

(美国: +1-631-791-1145)
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )


给我们发送电子邮件

sales@imarcgroup.com

Baidu